Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Prospective, Observational Study of Individuals Who Seroconvert While Taking Truvada® for Pre-Exposure Prophylaxis (PrEP)

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2016 by Gilead Sciences
Information provided by (Responsible Party):
Gilead Sciences Identifier:
First received: July 15, 2013
Last updated: February 18, 2016
Last verified: February 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2018
  Estimated Primary Completion Date: June 2018 (Final data collection date for primary outcome measure)